Letters Blood pressure lowering

Do black patients with chronic kidney disease benefit equally from all blood pressure lowering agents?

BMJ 2014; 348 doi: http://dx.doi.org/10.1136/bmj.g142 (Published 15 January 2014) Cite this as: BMJ 2014;348:g142
  1. Joseph A Ladapo, assistant professor of medicine and population health1,
  2. Gbenga Ogedegbe, professor of medicine1
  1. 1New York University School of Medicine, New York,‎ NY‎ 10016, USA
  1. Joseph.Ladapo{at}nyumc.org

The Blood Pressure Lowering Treatment Trialists’ Collaboration performed a rigorous and insightful analysis of the impact of antihypertensive agents on cardiovascular outcomes in patients with and without chronic kidney disease.1 However, we believe the study’s conclusion that “there is little evidence to support the preferential choice of particular drug classes for the prevention of cardiovascular events in people with chronic kidney disease” should be treated with …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe